Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Natural killer cell memory precedes HLH in monozygotic twins discordant for chronic active Epstein-Barr virus disease

Blood (2023) 141 (17): 2151–2155.

https://doi.org/10.1182/blood.2022018309

Published: 2023

Includes: Supplemental data

Journal Articles

Ambiguous Diagnosis of Nodal T-Cell Lymphomas with T-Follicular Helper (TFH) Phenotype and Hodgkin Lymphoma - a Multicenter Pilot Study

Blood (2021) 138 (Supplement 1): 1403.

https://doi.org/10.1182/blood-2021-149358

Published: 2021

Journal Articles

Clinical Application of an Ex-Vivo Platform to Guide the Choice of Drug Combinations in Relapsed/Refractory Lymphoma; A Prospective Study

Blood (2021) 138 (Supplement 1): 720.

https://doi.org/10.1182/blood-2021-149331

Published: 2021

Journal Articles

A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma

Blood (2021) 138 (6): 452–463.

https://doi.org/10.1182/blood.2020010637

Published: 2021

Includes: Supplemental data

Journal Articles

Super-Enhancer-Driven TOX2 Mediates Oncogenesis in Natural Killer/T Cell Lymphoma

Jianbiao Zhou, MDPhD, Sabrina Hui Min Toh, BSc, Kalpnaa Balan, BSc, Tze King Tan, PhD, Yunlu Jia, MD, Jing Quan Lim, PhD, Choon Kiat Ong, PhDBSc, Soon Thye Lim, MBBS, MRCP, Tuan Zea Tan, Siok-Bian Ng, Takaomi Sanda, MD PhD, Wee-Joo Chng, MBBS, PhD FRCPath, FRCP

Blood (2020) 136 (Supplement 1): 17.

https://doi.org/10.1182/blood-2020-136244

Published: 2020

Journal Articles

MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphoma

Boheng Li, Junli Yan, The Phyu, Shuangyi Fan, Tae-Hoon Chung, Nurulhuda Mustafa, Baohong Lin, Lingzhi Wang, Pieter Johan Adam Eichhorn, Boon-Cher Goh, Siok-Bian Ng, Dennis Kappei, Wee-Joo Chng

Blood (2019) 134 (23): 2046–2058.

https://doi.org/10.1182/blood.2019000381

Published: 2019

Includes: Supplemental data

Journal Articles

Overexpressed Melk Promotes the Stability of EZH2 through Phosphorylation in Natural Killer/T Cell Lymphoma (NKTL)

Boheng Li, PhD, Dennis Kappei, PhD, Junli Yan, PhD, Pieter Eichhorn, PhD, Siok Bian Ng, FRCPA, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS

Blood (2018) 132 (Supplement 1): 2858.

https://doi.org/10.1182/blood-2018-99-110758

Published: 2018

Journal Articles

Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis

Phaik Ju Teoh, Omer An, Tae-Hoon Chung, Jing Yuan Chooi, Sabrina H. M. Toh, Shuangyi Fan, Wilson Wang, Bryan T. H. Koh, Melissa J. Fullwood, Melissa G. Ooi, Sanjay de Mel, Cinnie Y. Soekojo, Leilei Chen, Siok Bian Ng, Henry Yang, Wee Joo Chng

Blood (2018) 132 (12): 1304–1317.

https://doi.org/10.1182/blood-2018-02-832576

Published: 2018

Includes: Supplemental data

Journal Articles

Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma

Blood (2018) 132 (11): 1146–1158.

https://doi.org/10.1182/blood-2018-01-829424

Published: 2018

Includes: Supplemental data

Journal Articles

MAPKAP1 (Sin1), a Key Component of the MTORC2 Complex, Confers Resistance to Sorafenib and Correlates with Adverse Clinical Outcomes in Acute Myeloid Leukemia

Joseph David Khoury, MD, Ioanna Xagoraris, MD, Nikolaos Tsesmetzis, MSc., Ida Hed Hed Myrberg, PhD, Thale Kristin Olsen, Siok Bian Ng, Wee-Joo Chng, MBBS, PhD FRCPath, FRCP, Benedict Yan, Chin Hin Ng, MD MRCP, Michael Andreeff, MD PhD, L. Jeffrey Medeiros, MD, Hagop M. Kantarjian, MD, Herold Nikolas, MD PhD, Dan Grander, MD PhD, George Rassidakis, MD PhD

Blood (2017) 130 (Supplement 1): 3964.

https://doi.org/10.1182/blood.V130.Suppl_1.3964.3964

Published: 2017

Journal Articles

Quantitative Analysis of Multiplexed Immunofluorescence in T-Cell Lymphoma

Sanjay de Mel, BSc( Hons) BM (Hons) MRCP(UK) FRCPath, Shou- Nian Choo, Shuangyi Fan, Hoang Mai Phuong, Michal Hoppe, Wee Joo Chng, MB ChB, MRCP, PhD, Anand Jeyasekharan, Siok Bian Ng

Blood (2017) 130 (Supplement 1): 2800.

https://doi.org/10.1182/blood.V130.Suppl_1.2800.2800

Published: 2017

Journal Articles

EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma

Junli Yan, Boheng Li, Baohong Lin, Pei Tsung Lee, Tae-Hoon Chung, Joy Tan, Chonglei Bi, Xue Ting Lee, Viknesvaran Selvarajan, Siok-Bian Ng, Henry Yang, Qiang Yu, Wee-Joo Chng

Blood (2016) 128 (7): 948–958.

https://doi.org/10.1182/blood-2016-01-690701

Published: 2016

Includes: Supplemental data

Journal Articles

Prognostic Significance Of rs6773853 Susceptibility Locus In B-Cell Non-Hodgkin’s Lymphoma

Joycelyn Jie Xin Lee, MBBS, Glorijoy Shi En Tan, MBBS, Chee Hian Tan, MBBS, Summer Pan, Chiea Chuen Khor, Jianjun Liu, Jia Nee Foo, Soo Yong Tan, MBBS, MRCPath, Siok Bian Ng, Miriam Tao, MBBS, MRCP, Soon Thye Lim, MBBS, MRCP, Tiffany Tang, MBBS, MRCP

Blood (2013) 122 (21): 4249.

https://doi.org/10.1182/blood.V122.21.4249.4249

Published: 2013

Journal Articles

EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity

Junli Yan, Siok-Bian Ng, Jim Liang-Seah Tay, Baohong Lin, Tze Loong Koh, Joy Tan, Viknesvaran Selvarajan, Shaw-Cheng Liu, Chonglei Bi, Shi Wang, Shoa-Nian Choo, Norio Shimizu, Gaofeng Huang, Qiang Yu, Wee-Joo Chng

Blood (2013) 121 (22): 4512–4520.

https://doi.org/10.1182/blood-2012-08-450494

Published: 2013

Includes: Supplemental data

Journal Articles

ATM-dependent spontaneous regression of early Eμ- myc –induced murine B-cell leukemia depends on natural killer and T cells

J. Ludovic Croxford, Melissa Li Fang Tang, Meng Fei Pan, Caleb Weihao Huang, Neha Kamran, Cindy Meow Ling Phua, Wee Joo Chng, Siok Bian Ng, David H. Raulet, Stephan Gasser

Blood (2013) 121 (13): 2512–2521.

https://doi.org/10.1182/blood-2012-08-449025

Published: 2013

Includes: Supplemental data

Journal Articles

EZH2 Is Aberrantly Expressed and Plays a Pro-Proliferative Role Independent of Its Methyltransferase Activity in Natural Killer/T-Cell Lymphoma

Wee-Joo Chng, Assoc/Prof, Junli Yan, PhD, Siok-Bian NG, Jim Tay, Ph.D., Baohong Lin, BSc, Tze-Loong Koh, B.sc., Joy Tan, BSc, Viknesvaran Selvarajan, Shaw-Cheng Liu, B.sc., Chonglei Bi, B.sc., Gaofeng Huang, PhD, Qiang Yu, Ph.D.

Blood (2012) 120 (21): 3498.

https://doi.org/10.1182/blood.V120.21.3498.3498

Published: 2012

Journal Articles

Dysregulated MicroRNA Affects Pathways and Targets of Biological Relevance in Nasal-Type Natural Killer/T-Cell Lymphoma

Wee-Joo Chng, M.B.Ch.B, Junli Yan, PhD, Gaofeng Huang, PhD, Viknesvaran Selvarajan, BSc, Jim Tay, BSc, Baohong Lin, BSc, Chonglei Bi, B.sc., Joy Tan, BSc, Siok-Bian Ng, MB ChB

Blood (2011) 118 (21): 2637.

https://doi.org/10.1182/blood.V118.21.2637.2637

Published: 2011

Journal Articles

Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma

Siok-Bian Ng, Junli Yan, Gaofeng Huang, Viknesvaran Selvarajan, Jim Liang-Seah Tay, Baohong Lin, Chonglei Bi, Joy Tan, Yok-Lam Kwong, Norio Shimizu, Katsuyuki Aozasa, Wee-Joo Chng

Blood (2011) 118 (18): 4919–4929.

https://doi.org/10.1182/blood-2011-07-364224

Published: 2011

Includes: Supplemental data

Journal Articles

Gene Expression Profiling Reveals Activation of Multiple Oncogenic Pathways and Over-Expression of Survivin in the Pathogenesis of Extranodal Nasal-Type NK/T Cell Lymphoma.

Wee-Joo Chng, Viknesvaran Selvarajan, Gaofeng Huang, Jianbiao Zhou, MD, MS, Mark Law, Andrew L Feldman, MD, Salto-Tellez Manual, Siok-Bian Ng

Blood (2009) 114 (22): 3931.

https://doi.org/10.1182/blood.V114.22.3931.3931

Published: 2009

Journal Articles

MYC Activation Is a Common Transformation Event in Myeloma and Associated with Poor Prognosis.

Wee-Joo Chng, MD, Gaofeng Huang, Siok-Bian Ng, Marta Chesi, PhD, Leif Bergsagel, Rafael Fonseca

Blood (2009) 114 (22): 834.

https://doi.org/10.1182/blood.V114.22.834.834

Published: 2009

NARROW

Natural killer cell memory precedes HLH in monozygotic twins discordant for chronic active Epstein-Barr virus disease

Ambiguous Diagnosis of Nodal T-Cell Lymphomas with T-Follicular Helper (TFH) Phenotype and Hodgkin Lymphoma - a Multicenter Pilot Study

Clinical Application of an Ex-Vivo Platform to Guide the Choice of Drug Combinations in Relapsed/Refractory Lymphoma; A Prospective Study

A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma

Super-Enhancer-Driven TOX2 Mediates Oncogenesis in Natural Killer/T Cell Lymphoma

MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphoma

Overexpressed Melk Promotes the Stability of EZH2 through Phosphorylation in Natural Killer/T Cell Lymphoma (NKTL)

Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis

Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma

MAPKAP1 (Sin1), a Key Component of the MTORC2 Complex, Confers Resistance to Sorafenib and Correlates with Adverse Clinical Outcomes in Acute Myeloid Leukemia

Quantitative Analysis of Multiplexed Immunofluorescence in T-Cell Lymphoma

EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma

Prognostic Significance Of rs6773853 Susceptibility Locus In B-Cell Non-Hodgkin’s Lymphoma

EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity

ATM-dependent spontaneous regression of early Eμ- myc –induced murine B-cell leukemia depends on natural killer and T cells

EZH2 Is Aberrantly Expressed and Plays a Pro-Proliferative Role Independent of Its Methyltransferase Activity in Natural Killer/T-Cell Lymphoma

Dysregulated MicroRNA Affects Pathways and Targets of Biological Relevance in Nasal-Type Natural Killer/T-Cell Lymphoma

Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma

Gene Expression Profiling Reveals Activation of Multiple Oncogenic Pathways and Over-Expression of Survivin in the Pathogenesis of Extranodal Nasal-Type NK/T Cell Lymphoma.

MYC Activation Is a Common Transformation Event in Myeloma and Associated with Poor Prognosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only